S-4/A Filing

STRATA CRITICAL MEDICAL, INC. CIK: 1779128

Filing Information

Form Type	S-4/A
Accession Number	`0001104659-21-034094`
Period End Date	20201231
Filing Date	20210310
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	expcu-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 45 Income Statement 21 Cash Flow Statement 36 Stockholders Equity 18

Balance Sheet 45 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$846.07K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$125.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$50.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$896.07K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.43M	USD	Point-in-time
Marketable securities held in Trust Account	`MarketableSecuritiesNoncurrent`	$276.26M	USD	Point-in-time
Marketable securities held in Trust Account	`MarketableSecuritiesNoncurrent`	$276.94M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$277.84M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$277.69M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$158.95K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$136.69K	USD	Point-in-time
Accrued offering costs	`AccruedOfferingCosts`	$26.00K	USD	Point-in-time
Accrued offering costs	`AccruedOfferingCosts`	$26.00K	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$208.61K	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$205.84K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$371.31K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$390.79K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeePayable`	$9.62M	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeePayable`	$9.62M	USD	Point-in-time
Total Liabilities	`Liabilities`	$10.00M	USD	Point-in-time
Total Liabilities	`Liabilities`	$10.02M	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A common stock subject to possible redemption 26,136,620 and 26,180,927 shares at redemption value as of December 31, 2020 and 2019, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$262.82M	USD	Point-in-time
Class A common stock subject to possible redemption 26,136,620 and 26,180,927 shares at redemption value as of December 31, 2020 and 2019, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$262.70M	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.09M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.21M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$784.78K	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$912.50K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$277.84M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$277.69M	USD	Point-in-time

Income Statement 21 line items

Line Item	Tag	Value	Unit	Period
Operating costs	`OperatingExpenses`	$268.21K	USD	2 Qtrs
Operating costs	`OperatingExpenses`	$678.49K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-678.49K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-268.21K	USD	2 Qtrs
Interest income on marketable securities held in Trust Account	`InvestmentIncomeDividend`	$1.26M	USD	2 Qtrs
Interest income on marketable securities held in Trust Account	`InvestmentIncomeDividend`	$1.02M	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$993.39K	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$338.18K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$208.61K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$210.47K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$208.61K	USD	2 Qtrs
Net income	`NetIncomeLoss`	$784.78K	USD	2 Qtrs
Net income	`NetIncomeLoss`	$127.72K	USD	Annual
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption	`TemporaryEquityBasicAndDilutedWeightedAverageSharesOutstanding`	26.19M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption	`TemporaryEquityBasicAndDilutedWeightedAverageSharesOutstanding`	26.16M	shares	Annual
Basic and diluted net income per share, Common stock subject to possible redemption	`TemporaryEquityBasicAndDilutedWeightedAveragePerShares`	$0.02	USD	Annual
Basic and diluted net income per share, Common stock subject to possible redemption	`TemporaryEquityBasicAndDilutedWeightedAveragePerShares`	$0.03	USD	2 Qtrs
Basic and diluted weighted average shares outstanding, Common stock	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.17M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding, Common stock	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.21M	shares	Annual
Basic and diluted net loss per common share, common stock	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	2 Qtrs
Basic and diluted net loss per common share, common stock	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual

Cash Flow Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$127.72K	USD	Annual
Net income	`ProfitLoss`	$784.78K	USD	2 Qtrs
Interest earned on marketable securities held in Trust Account	`InterestEarnedOnMarketableSecuritiesHeldInTrustAccountOperatingActivities`	$1.26M	USD	2 Qtrs
Interest earned on marketable securities held in Trust Account	`InterestEarnedOnMarketableSecuritiesHeldInTrustAccountOperatingActivities`	$1.02M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$125.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-75.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$136.69K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$22.25K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedTaxesPayable`	$-2.77K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedTaxesPayable`	$208.61K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-794.47K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-256.51K	USD	2 Qtrs
Investment of cash in Trust Account	`InvestmentOfCashInTrustAccount`	$275.00M	USD	2 Qtrs
Cash withdrawn from Trust Account to pay franchise and income taxes	`ProceedsFromInvestmentIncomeInTrustAccountWithdrawnToPayFranchiseAndIncomeTaxes`	$334.93K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$334.93K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-275.00M	USD	2 Qtrs
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromIssuanceInitialPublicOffering`	$269.50M	USD	2 Qtrs
Proceeds from Issuance of Warrants	`ProceedsFromIssuanceOfWarrants`	$7.50M	USD	2 Qtrs
Proceeds from promissory notes - related party	`ProceedsFromRelatedPartyDebt`	$231.37K	USD	2 Qtrs
Repayment of promissory notes - related party	`RepaymentsOfRelatedPartyDebt`	$231.37K	USD	2 Qtrs
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$437.88K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$276.56M	USD	2 Qtrs
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-459.54K	USD	Annual
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.31M	USD	2 Qtrs
Cash - Beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$846.07K	USD	Point-in-time
Cash - Beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash - Beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31M	USD	Point-in-time
Cash - Ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$846.07K	USD	Point-in-time
Cash - Ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash - Ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$213.23K	USD	Annual
Initial classification of Class A common stock subject to redemption	`InitialClassificationOfCommonStockSubjectToPossibleRedemptionNonCashActivities`	$261.91M	USD	2 Qtrs
Change in value of Class A common stock subject to possible redemption	`ChangeInValueOfCommonStockSubjectToPossibleRedemptionNonCashActivities`	$127.72K	USD	Annual
Change in value of Class A common stock subject to possible redemption	`ChangeInValueOfCommonStockSubjectToPossibleRedemptionNonCashActivities`	$786.07K	USD	2 Qtrs
Deferred underwriting fee payable	`DeferredUnderwritingFeePayableNonCashActivities`	$9.62M	USD	2 Qtrs
Offering costs paid directly by Sponsor in exchange for the issuance of Class B common stock to Sponsor	`DeferredOfferingCostsPaidDirectlyBySponsorFromProceedsOfIssuanceOfCommonStockToSponsorNonCashActivities`	$25.00K	USD	2 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Sale of Private Placement Warrants (in shares)	`StockIssuedDuringPeriodSharesNewIssuesPrivatePlacementWarrants`	5.00M	shares	Annual
Balance at the beginning	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	-	USD	Point-in-time
Issuance of Founder Shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	Point-in-time
Issuance of Founder Shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	2 Qtrs
Issuance of Founder Shares to Sponsor (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	7.19M	shares	Point-in-time
Forfeiture of Founder Shares	`StockRepurchasedAndRetiredDuringPeriodValue`	-	USD	2 Qtrs
Forfeiture of Founder Shares (in shares)	`StockRepurchasedAndRetiredDuringPeriodShares`	312,500.00	shares	Annual
Sale of 27,500,000 Units, net of underwriting discount and offering expenses	`StockIssuedDuringPeriodValueIssuanceOfUnitsNetOfExpenses`	$259.39M	USD	2 Qtrs
Sale of 5,000,000 Private Placement Warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$7.50M	USD	2 Qtrs
Common stock subject to possible redemption	`StockRedeemedOrCalledDuringPeriodValue`	$262.70M	USD	2 Qtrs
Common stock subject to possible redemption	`CommonStockSubjectToPossibleRedemptionValue`	$-127.72K	USD	Annual
Net (loss) income	`NetIncomeLoss`	$784.78K	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$127.72K	USD	Annual
Balance at the end	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$5.00M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.